High-Dose Aflibercept for Neovascular AMD and DME in Suboptimal Responders to Standard-Dose Aflibercept.

Nielsen, Jared S; Roberts, Carter L; Saggau, David D; Alliman, Kyle J

Nielsen, Jared S; Roberts, Carter L; Saggau, David D; Alliman, Kyle J.

Afiliação

Nielsen JS; Vitreoretinal Diseases and Surgery, Wolfe Eye Clinic, West Des Moines, IA, USA.
Roberts CL; Vitreoretinal Diseases and Surgery, Wolfe Eye Clinic, West Des Moines, IA, USA.
Saggau DD; Vitreoretinal Diseases and Surgery, Wolfe Eye Clinic, West Des Moines, IA, USA.
Alliman KJ; Vitreoretinal Diseases and Surgery, Wolfe Eye Clinic, West Des Moines, IA, USA.

J Vitreoretin Dis ; 7(2): 116-124, 2023.

Article em En | MEDLINE | ID: mdl-37006663

Palavras-chave

aflibercept; age-related macular degeneration; anti-VEGF; diabetic macular edema

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Vitreoretin Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google